- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 351.06M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 353.18M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 218.6M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $299.32M |
| Capex | Q1 2026 · Mar 31, 2025 | $117.93M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$18.25M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$18.84M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $758.51M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $568.23M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.34B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.06B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $164.72M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $176.82M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.24B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $992.4M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.21B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $911.64M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.11B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.58B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.05 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $11.1M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $6.52M |
| Net Income | Q1 2026 · Mar 31, 2026 | $4.63M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$11.53M |